Tokyo, Japan

Mutsauo Suzuki

This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1995.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mutsauo Suzuki: Innovator in Milbemycin Derivatives

Introduction

Mutsauo Suzuki is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the production of milbemycin derivatives. His innovative work has led to the development of processes that enhance the synthesis of these important compounds.

Latest Patents

Mutsauo Suzuki holds a patent for "Processes for the production of 13-ether derivatives of milbemycins." This patent includes an intermediate that is useful in the synthesis of milbemycin derivatives featuring an ether bond at the 13-position. The general formula for this compound is represented as (IIId), where R can be a methyl group, an ethyl group, an isopropyl group, or a sec-butyl group. Additionally, R⁵ and R⁶ each represent either a hydrogen atom or a protecting group. This patent showcases his expertise in organic chemistry and the development of pharmaceutical compounds.

Career Highlights

Mutsauo Suzuki is associated with Sankyo Company, Limited, where he has been able to apply his innovative ideas in a corporate setting. His work has not only contributed to the company's research and development efforts but has also advanced the field of medicinal chemistry.

Collaborations

Mutsauo Suzuki has collaborated with notable colleagues such as Shunshi Kojima and Mitsugi Shibano. These partnerships have fostered a creative environment that encourages the exchange of ideas and the advancement of research in their respective fields.

Conclusion

Mutsauo Suzuki's contributions to the field of milbemycin derivatives highlight his innovative spirit and dedication to advancing chemical processes. His work continues to influence the pharmaceutical industry and showcases the importance of collaboration in scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…